[vc_row][vc_column][vc_column_text]
Organized by the ISCT MSC Scientific Committee
Pre-Conference Workshop
Wednesday, May 29, 2019
8:30 – 16:15
Room: 219
The 2019 MSC Pre-Conference Workshop will highlight a variety of clinical applications including orthopedics, neuroscience, targeted organ therapies and orofacial diseases. The workshop will bring together leading scientists, clinicians, regulators and product developers to share their latest clinical trial results and future perspectives on the translation of MSC therapies. [/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”Register Now” color=”warning” align=”center”][vc_column_text]
Supporters
 |  |
 | |
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Program Information
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_tta_accordion color=”blue” active_section=”1″][vc_tta_section title=”Session 1 – Clinical Trials Part 1: MSC Sources, Applications and ‘Off the Shelf’ Products” tab_id=”1549316696032-1025b7ba-8ed4″][vc_column_text]Session Chair:
Yufang Shi, PhD, Institutes for Translational Medicine, China
Speakers:
Paul Simmons, PhD, Mesoblast, Australia
Igor Slukvin, MD, PhD, Univeristy of Wisconsin, USA
iPSC-Derived Mesenchymal and Vascular Progenitor: A Novel Technology Platform for Regenerative Medicine
Robert W. Mays, PhD, Athersys Inc., USA
Clinical Development of MultiStem®, an Adult Stem Cell Therapy, for Treatment of Acute Injuries of the Central Nervous System
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Session 2 – Clinical Trials Part II: Asia Pacific Spotlight” tab_id=”1549316696032-588f8efd-6cec”][vc_column_text]Session Chair:
Donald G. Phinney, PhD, Scripps Research Institute, USA
Speakers:
Pawan Kumar Gupta, MBBS, MD, DNB, PhD, Stempeutics Research, India
Therapeutic Potential of Bone Marrow-derived, pooled, Allogeneic Mesenchymal Stromal Cells (Stempeucel®) for Patients with Critical Limb Ischemia due to Buerger’s disease
Andy Peng Xiang, Sun Yat-Sen University, China
From bench to bedside — the clinical study of mesenchymal stem/stromal cell therapy for acute inflammatory response syndrome
Fu-Sheng Wang, MD, PhD, Beijing 302 Hospital, China
Oscar K. Lee, MD, PhD, National Yang Ming University, Taiwan
Treatment of Spinocerebellar Ataxia with Allogeneic mesenchymal Stem Cells
[/vc_column_text][vc_column_text][/vc_column_text][/vc_tta_section][vc_tta_section title=”Next Generation MSC Technologies (Industry Luncheon Presented by RoosterBio Inc.)” tab_id=”1549498463814-6282c183-ab0d”][vc_column_text]Chair:
Jon A. Rowley, PhD, RoosterBio Inc, United States
Speakers:
Jon A. Rowley, PhD, RoosterBio Inc, United States
Radically Simplifying Scale-up and Clinical Translation of hMSCs and Extracellular Vesicles
John Davies, PhD, DSc, Tissue Regeneration Therapeutics Inc., Canada
Engineered MSCs as Targeted Therapeutics[/vc_column_text][/vc_tta_section][vc_tta_section title=”Session 3 – MSC Regulatory Landscape” tab_id=”1549316969653-b44d4590-c780″][vc_column_text]Session Chair:
Sowmya Viswanathan, PhD, University Health Network, Canada
Speakers:
Yoji Sato, PhD, Division of Cell-Based Therapeutic Products, National Institute of Health, Japan
The Regulatory Landscape Around Cell Therapy and Regenerative Medicine in Japan
Willem Fibbe, MD, PhD, Leiden University Medical Center, Netherlands
A Translational Perspective on MSC Therapies
Tony Manderson, PhD, Head of Cell & Tissue Therapies Unit, TGA
Regulatory landscape for cell and gene therapies in Australia
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Session 4 – Clinical Trials Part III: Characterization and Future Perspectives” tab_id=”1549316972289-aab5dd81-ea57″][vc_column_text]Session Chair:
Donald G. Phinney, PhD, Scripps Research Institute, USA
Speakers:
Songtao Shi, DDS, PhD, South China Center of Craniofacial Stem Cell Research, Guanghua School of Stomatology, Sun Yat-sen University, China
Epigenetic Regulation in Mesenchymal Stem Cell Immune Therapies
Yufang Shi, PhD, Institutes for Translational Medicine, China
Inflammation and MSC Therapy Design
Luis Ortiz, PhD, University of Pittsburgh, USA
The Characterization and Rational of the use of MSC on the Treatment of Fibrotic Lung Diseases: Improving Pulmonary Hypertension and the Removal of Collagen
[/vc_column_text][/vc_tta_section][/vc_tta_accordion][vc_column_text]
To view the full meeting program visit Program Schedule.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Organizing Committee
Yufang Shi, PhD – Co-Chair
Professor
Institutes for Translational Medicine
Suzhou, China
Donald G. Phinney, PhD – Co-Chair
Professor
Scripps Research Institute
Jupiter, FL, United States
[/vc_column_text][/vc_column][/vc_row]